Theratechnologies Inc T.TH

Chronic undervaluation

[Biobob]

The total lack of interest from buyers at 2 times sales is disturbing.. considering there is potential (FDA Fast Track potential, Nash p.3 potential).. considering Marathon is willing to lend them money for 100M max... stupid volumes, no analyst report to support the stock even if they want to raise money in a near future.  Many other tax loss candidates than Th this year also.  I don't get it that selling this story can be so dam difficult.  Paul was hailed as a great salesman by our Chairwomen.... it's making all shareholders angry atm that nothing can be done about it because these markets are sooooooooooo difficult. Yes but 2 times sales once again and some giganourmous potential not that far away is clearly not told and pushed and hussled to potential investors the way it should.  It can't considering the stupid.. I repeat stupid value and recognition we shareholders are getting atm.  But for that someone has to pound the table overthere.

[Momo25]

FDA fast track does not mean anything. A proof of concept does not need 2 years to proven . Big pharmas know that. If Nash program  is of interest the big pharmas who sit on billions of dollars due to COVID pandemic will jump in. Marathon line of credit is not at risk even if the oncology program fails because TH still have revenue from the legacy drug.  the market is giving the right

[Biobob]

Whatever... good weekend and happy Hollowen.  We're used to Terror with our Terror Technologies nightmare on Baystreet.